N. Anthony Coles, CEO and Chairperson at Cerevel Therapeutics Holdings, Inc. (CERE), sold 50,000 shares at $29.93 ($1.5M) on 2023-01-05, disclosed to the SEC on 2023-01-06.
Open-market sale of $1.5M CERE by CEO and Chairperson. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.93 | 49,500 | $1.5M | 99.0% |
| 2 | $30.73 | 500 | $15K | 1.0% |
| Total | $29.94 avg | 50,000 | $1.5M | 100% |
| Filing → |
| CERE | SELL | 2024-05-14 | $2.1M | — | Filing → |
| CERE | SELL | 2024-04-03 | $2.1M | — | Filing → |
| CERE | SELL | 2024-03-06 | $2.1M | — | Filing → |